Antidressiva
| Therapeutischer Bereich | Halbwertszeit | Proteinbindung | Methode | |
|---|---|---|---|---|
| ng/ml | h | % | ||
| Amitriptylin + Nortriptylin | 80-200 | 15/26 | 98/93 | HPLC-UVD |
| EsCitalopram / Citalopram | 15-80 / 30-130 | 30 | 80 | HPLC-UVD |
| Clomipramin + NorClomipramin | 175-450 | 21/66 | 97 | HPLC-UVD |
| Desipramin | 100-300 | 17 | 82 | HPLC-UVD |
| Doxepin + NorDoxepin | 50-150 | 11/57 | 80 | HPLC-UVD |
| Duloxetin | 20-80 | 13 | 95 | HPLC-UVD |
| Fluoxetin + NorFluoxetin | 120-300 | 96/192 | 95 | HPLC-UVD |
| Fluvoxamin | 150-300 | 20 | 77 | HPLC-UVD |
| Imipramin + Desipramin | 175-300 | 11/17 | 89/82 | HPLC-UVD |
| Maportilin | 125-200 | 38 | 88 | HPLC-UVD |
| Mirtazapin | 40-80 | 30 | 85 | HPLC-FLD |
| Nortryptilin | 70-170 | 26 | 93 | HPLC-UVD |
| Paroxetin | 70-120 | 24 | 95 | HPLC-UVD |
| Reboxetin | 10-100 | 13 | 98 | HPLC-UVD |
| Sertralin | 10-50 | 26 | 98 | HPLC-UVD |
| Trimipramin | 10-300 | 17 | 95 | HPLC-UVD |
| Venlafaxin + Desmethylvenlafaxin | 80-200 | 5/11 | 35 | HPLC-FLD |
| Talspiegel gemäß Konsensusleitlinien der AGNP-TDM-Arbeitsgruppe | ca. Werte | ca. Werte |
